Can beta-glucuronidase-producing gut bacteria increase estrogen and xenobiotic reabsorption?

Under normal physiological conditions, the liver coordinates the clearance of endogenous estrogens and exogenous xenobiotics. Through Phase II conjugation, UDP-glucuronosyltransferases attach glucuronic acid to these compounds, converting them into water-soluble, biologically inactive glucuronide conjugates destined for biliary excretion and fecal elimination. However, the activity of specific gut microbiota can reverse this detoxification pathway.

Mechanistic pathways of deconjugation

• Enzymatic hydrolysis: Gut microbes expressing the enzyme beta-glucuronidase (GUS)—often referred to as the estrobolome in the context of estrogen metabolism—catalyze the cleavage of the glucuronide bond from excreted conjugates.
• Restoration of lipophilicity: This deconjugation reaction removes the polar glucuronic acid tag, restoring the lipophilic, biologically active state of the parent estrogens and xenobiotics.
• Enterohepatic recirculation: Because the freed compounds are lipid-soluble, they are readily reabsorbed across the intestinal mucosa, entering the portal circulation and returning to systemic circulation.

Clinical and systemic implications

• Increased systemic estrogen: By preventing the excretion of estrogens and promoting their reabsorption, elevated beta-glucuronidase activity directly increases circulating estrogen levels.
• Hormone-driven pathology: Prolonged systemic exposure to elevated estrogens is directly linked to an increased risk of hormone-driven conditions, such as breast cancer, endometriosis, and uterine fibroids. This pathway is particularly relevant for managing breast cancer risk and endocrine health in postmenopausal women.
• Extended xenobiotic half-life: This recirculation loop similarly extends the biological half-life and potential systemic toxicity of specific xenobiotics and pharmacological agents.

Bottom line

• Elevated gut microbial beta-glucuronidase activity directly reverses hepatic detoxification by deconjugating biliary-excreted estrogen and xenobiotic glucuronides, restoring their active, lipophilic forms and driving enterohepatic recirculation and increased systemic exposure.